Permanently Discontinued

CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV

BRACCO IMAGING CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV 52% has been permanently discontinued (last updated December 20, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file1 product

Affected strength52%

Last updated2018-12-20

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

CHOLOGRAFIN MEGLUMINE INJ

SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC.

52% · DIN 00183873

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02228556

Strength

52%

Dosage Form

LIQUID

Route

INTRAVENOUS

Active Ingredient

MEGLUMINE IODIPAMIDE

See all MEGLUMINE IODIPAMIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2018-12-20

Active Shortage

Disruption of the manufacture of the drug.

Other Products from BRACCO IMAGING CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

DIN 02228564

41% · DIN 02229013

61% · DIN 02229021

76% · DIN 02229048

61% · DIN 02242122

76% · DIN 02242121